Altimmune, Inc.
(NASDAQ : ALT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
ETSYEtsy, Inc. 2.31%111.757.9%$590.79m
CHGGChegg, Inc. -1.70%64.1515.3%$184.04m
FLTFleetCor Technologies, Inc. 2.49%241.803.5%$162.93m
CPRTCopart, Inc. 1.38%103.664.4%$154.67m
CDAYCeridian HCM Holding, Inc. -0.74%75.030.0%$124.93m
EFXEquifax, Inc. -2.02%155.942.0%$124.73m
BFAMBright Horizons Family Solutions, Inc. -1.32%139.521.4%$79.22m
KCKingsoft Cloud Holdings Ltd. -0.41%38.670.0%$73.34m
PAGSPagSeguro Digital Ltd. -0.05%37.470.0%$68.74m
STMPStamps.com, Inc. 6.07%225.8824.9%$67.95m
CRLCharles River Laboratories International, Inc. 0.68%219.634.5%$65.22m
BAHBooz Allen Hamilton Holding Corp. -0.25%84.612.0%$65.21m
BANDBandwidth, Inc. 3.08%154.680.0%$63.26m
MEDPMedpace Holdings, Inc. -3.40%112.530.9%$60.78m
BRBroadridge Financial Solutions, Inc. -1.51%131.461.5%$58.25m

Company Profile

Altimmune, Inc. is a clinical stage immunotherapeutic biotechnology company. It focuses on the discovery and development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. The company's portfolio includes RespirVec and Densigen that targets to stimulate the elements of the human immune system to treat respiratory diseases, chronic infections, and cancer. Altimmune was founded in 1997 and is headquartered in Gaithersburg, MD.